Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Brigitta G Baumert"'
Autor:
Sophie Pietschmann, André O von Bueren, Michael J Kerber, Brigitta G Baumert, Rolf Dieter Kortmann, Klaus Müller
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0121592 (2015)
To determine the characteristics, treatments and outcomes of patients with glioblastoma multiforme (GBM) or gliosarcoma (GS) and metastases outside of the central nervous system (CNS).PubMed and Web of Science searches for peer-reviewed articles pert
Externí odkaz:
https://doaj.org/article/c3d68f5d25fc485eadc5c829455f42a6
Autor:
Nam Phong Nguyen, Ulf Lennart Karlsson, David Lehrman, Thandeka Mazibuko, Tatul Saghatelyan, Juliette Thariat, Brigitta G. Baumert, Vincent Vinh-Hung, Olena Gorobets, Huan Giap, Sankalp Singh, Alexander Chi, Graciana Alessandrini, Abhinav Ahluwalia, Francis Durosinmi-Etti, Jorge Zegarra Cárdenas, Koniba Diabate, Joan Oboite, Eromosele Oboite, Tahir Mehmood, Te Vuong, Lyndon Kim, Brandi R. Page
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Older cancer patients are disproportionally affected by the Coronavirus 19 (COVID-19) pandemic. A higher rate of death among the elderly and the potential for long-term disability have led to fear of contracting the virus in these patients. This fear
Externí odkaz:
https://doaj.org/article/6ae5ef51ce3849438f1064a78041860d
Autor:
Peter Sminia, Jan Theys, Bart A. Westerman, Brigitta G. Baumert, Lukas J.A. Stalpers, Daphne A. Haas-Kogan, Tom Würdinger, Ben J. Slotman, Jaap van den Berg, Rogier Dik, Hou Y.Y.E. Veldman, Tonny Lagerweij, Fleur M.G. Cornelissen, Paul L.G. Slangen, Ana Gasol, Ravi S. Narayan
Supplemental Figure 1. Chemical structures of non-FDA approved compounds used in the Study; Supplemental Figure 2. Effect of drugs on growth and target phosphorylation; Supplemental Figure 3. mTOR inhibition does not show dose dependent Radiosensitiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc0c910cffbb13d392e1d82fa7f189d
https://doi.org/10.1158/1535-7163.22504666.v1
https://doi.org/10.1158/1535-7163.22504666.v1
Autor:
Peter Sminia, Jan Theys, Bart A. Westerman, Brigitta G. Baumert, Lukas J.A. Stalpers, Daphne A. Haas-Kogan, Tom Würdinger, Ben J. Slotman, Jaap van den Berg, Rogier Dik, Hou Y.Y.E. Veldman, Tonny Lagerweij, Fleur M.G. Cornelissen, Paul L.G. Slangen, Ana Gasol, Ravi S. Narayan
Glioblastoma (GBM) is a highly aggressive and lethal brain cancer type. PI3K and MAPK inhibitors have been studied preclinically in GBM as monotherapy, but not in combination with radiotherapy, which is a key component of the current standard treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99956e3c52b0c80f5b93b220beab0d8d
https://doi.org/10.1158/1535-7163.c.6537823.v1
https://doi.org/10.1158/1535-7163.c.6537823.v1
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Supplementary Data from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109744a2c92862781132af0ecf222543
https://doi.org/10.1158/1078-0432.22487442
https://doi.org/10.1158/1078-0432.22487442
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Purpose:In a post hoc analysis of the CATNON trial (NCT00626990), we explored whether adding temozolomide to radiotherapy improves outcome in patients with IDH1/2 wildtype (wt) anaplastic astrocytomas with molecular features of glioblastoma [redesign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b32e4e9c69dd0eaf37cef44fe94660
https://doi.org/10.1158/1078-0432.c.6532518
https://doi.org/10.1158/1078-0432.c.6532518
Autor:
Martin J. van den Bent, Pim J. French, Thierry Gorlia, Brigitta G. Baumert, Vassilis Golfinopoulos, Kin Jip Cheung, Wilfred F.J. van IJcken, Rutger W.W. Brouwer, Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Iris de Heer, Youri Hoogstrate, Andreas von Deimling, Pieter Wesseling, Johan M. Kros, Robert B. Jenkins, Kenneth Aldape, Myra E. van Linde, Catherine McBain, Michael Weller, Roberta Rudà, Walter Taal, Leland Rogers, Matthew Griffin, Sanjeev Gill, Olivier L. Chinot, Helen Wheeler, Warren P. Mason, Jean-Francois Baurain, Anna K. Nowak, Michael A. Vogelbaum, Sara C. Erridge, Paul M. Clement, Alba A. Brandes, Wolfgang Wick, Marc Sanson, C. Mircea S. Tesileanu
Supplementary Figure from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d66230eb0256698fea2e10f6ea94c9
https://doi.org/10.1158/1078-0432.22487427.v1
https://doi.org/10.1158/1078-0432.22487427.v1
Autor:
Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, Michael Weller, Timothy Cloughesy, Jana Portnow, Ovidiu Andronesi, Jill S Barnholtz-Sloan, Brigitta G Baumert, Mitchell S Berger, Wenya Linda Bi, Ranjit Bindra, Daniel P Cahill, Susan M Chang, Joseph F Costello, Craig Horbinski, Raymond Y Huang, Robert B Jenkins, Keith L Ligon, Ingo K Mellinghoff, L Burt Nabors, Michael Platten, David A Reardon, Diana D Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin van den Bent, William G Kaelin, Patrick Y Wen
Publikováno v:
Neuro-Oncology, 25(1), 4-25. Oxford University Press
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant primary brain tumors diagnosed in patients younger than 50, constituting an important cause of morbidity and mortality. In recent years, there has been significant pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7888e20bfb658ca64d596b23bad01a7a
https://pure.eur.nl/en/publications/fbf82a24-927c-437d-a863-4c29db0953f1
https://pure.eur.nl/en/publications/fbf82a24-927c-437d-a863-4c29db0953f1
Autor:
Nam P. Nguyen, Lyndon Kim, Juliette Thariat, Brigitta G. Baumert, Thandeka Mazibuko, Olena Gorobets, Vincent Vinh-Hung, Huan Giap, Tahir Mehmood, Felix Vincent, Alexander Chi, Trinanjan Basu, Gokoulakrichenane Loganadane, Mohammad Mohammadianpanah, Ulf Karlsson, Eromosele Oboite, Joan Oboite, Ahmed Ali, Brandi R. Page
Publikováno v:
Cancers. 14(21)
The standard of care for locally advanced head and neck cancer is concurrent chemoradiation or postoperative irradiation with or without chemotherapy. Surgery may not be an option for older patients (70 years old or above) due to multiple co-morbidit
Autor:
Vasilis Golfinopoulos, Roger Stupp, Mohamed Ben Hassel, Jaap C. Reijneveld, Martin J B Taphoorn, A Josephine Drijver, Andreas F. Hottinger, Thierry Gorlia, Elodie Vauleon, Khê Hoang-Xuan, Daniëlle B.P. Eekers, Salvador Villà Freixa, Brigitta G. Baumert, Martin J. van den Bent, Tzahala Tzuk-Shina, Jacolien E.C. Bromberg, A. Lucas, Martin Klein
Publikováno v:
Neuro-Oncology, 23(5), 803-811. Oxford University Press
Neuro-oncology, vol. 23, no. 5, pp. 803-811
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2020, 23 (5), pp.803-811. ⟨10.1093/neuonc/noaa252⟩
Neuro-oncology, 23(5), 803-811. Oxford University Press
Neuro Oncol
Klein, M, Drijver, A J, van den Bent, M J, Bromberg, J C, Hoang-Xuan, K, Taphoorn, M J B, Reijneveld, J C, Ben Hassel, M, Vauleon, E, Eekers, D B P, Tzuk-Shina, T, Lucas, A, Freixa, S V, Golfinopoulos, V, Gorlia, T, Hottinger, A F, Stupp, R & Baumert, B G 2021, ' Memory in low-grade glioma patients treated with radiotherapy or temozolomide : a correlative analysis of EORTC study 22033-26033 ', Neuro-Oncology, vol. 23, no. 5, pp. 803-811 . https://doi.org/10.1093/neuonc/noaa252
Dipòsit Digital de la UB
Universidad de Barcelona
Neuro-Oncology, 23(5), 803-811. OXFORD UNIV PRESS INC
Neuro-oncology, vol. 23, no. 5, pp. 803-811
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2020, 23 (5), pp.803-811. ⟨10.1093/neuonc/noaa252⟩
Neuro-oncology, 23(5), 803-811. Oxford University Press
Neuro Oncol
Klein, M, Drijver, A J, van den Bent, M J, Bromberg, J C, Hoang-Xuan, K, Taphoorn, M J B, Reijneveld, J C, Ben Hassel, M, Vauleon, E, Eekers, D B P, Tzuk-Shina, T, Lucas, A, Freixa, S V, Golfinopoulos, V, Gorlia, T, Hottinger, A F, Stupp, R & Baumert, B G 2021, ' Memory in low-grade glioma patients treated with radiotherapy or temozolomide : a correlative analysis of EORTC study 22033-26033 ', Neuro-Oncology, vol. 23, no. 5, pp. 803-811 . https://doi.org/10.1093/neuonc/noaa252
Dipòsit Digital de la UB
Universidad de Barcelona
Neuro-Oncology, 23(5), 803-811. OXFORD UNIV PRESS INC
Background EORTC study 22033–26033 showed no difference in progression-free survival between high-risk low-grade glioma receiving either radiotherapy (RT) or temozolomide (TMZ) chemotherapy alone as primary treatment. Considering the potential long